Immunotherapy
- Ministry of Science & Technology
DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9
Cancer kills 8.51 lakh people in India every year (International Agency for Research on Cancer, 2020,Globocan). As per World Health…
Read More » - Business
Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020
LACHEN, Switzerland: Octapharma announces that the final results from the phase III ProDERM study will be presented at the American…
Read More »